CytomX Therapeutics, Inc. CTMX
- Varseta-M — Colorectal Cancer Phase 1
- Varseta-M — Gastric Cancer Phase 1
- Varseta-M — Pancreatic Ductal Adenocarcinoma Phase 1
- Varseta-M — Biliary Tract Cancer Phase 1
EpCAM (1 companies · 4 programs)
Companies with an active program directed at EpCAM.